Skip to main content
    S

    Sabra Healthcare REIT Inc (SBRA)

    Official site

    REAL ESTATE • REIT - HEALTHCARE FACILITIES • NASDAQ

    $20.35
    -0.09 (-0.44%)

    Market Cap: $5.35B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Sabra Healthcare REIT Inc (SBRA) Financials: Revenue, Profit and Cash Flow

    Updated Nov 2, 2026. Financial statements from company filings, amounts in US dollars.

    Sabra Healthcare REIT reported revenue of $787.51M for the fiscal year ended Dec 31, 2025, up 11.6% from the year before. That year, net income was $155.51M with a net margin of 19.7%, operating cash flow was $348.61M and free cash flow was $307.09M. The quarter ended Sep 30, 2026 had revenue of $220.15M and net income of $28.56M.

    Revenue and Margins

    The operating margin was 33.5% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $264.52M, a compound annual rate of 12.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$787.51M+11.6%63.9%33.5%19.7%
    Dec 2024$705.97M+8.9%67.4%36.4%17.9%
    Dec 2023$648.57M+25.2%69.7%34.2%2.1%
    Dec 2022$517.83M+18.6%89.3%45.4%-15.0%
    Dec 2021$436.66M-25.5%98.1%48.3%-25.9%
    Dec 2020$586.45M-9.4%79.6%41.1%23.6%
    Dec 2019$647.49M+3.6%86.3%81.5%10.7%
    Dec 2018$624.97M+95.4%91.8%49.1%44.7%
    Dec 2017$319.82M+20.9%121.3%70.2%49.5%
    Dec 2016$264.52MN/A96.3%60.8%26.5%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 22.7% from the year before. In the quarter ended Sep 2026, net income rose 26.8% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$787.51M$705.97M$648.57M$517.83M$436.66M$586.45M$647.49M$624.97M$319.82M$264.52M
    Cost of revenue$271.11M$227.09M$195.25M$162.61M$141.20M$131.55M$109.71M$49.55M$17.86M$5.70M
    Gross profit$503.53M$476.15M$452.27M$462.20M$428.34M$467.02M$558.48M$573.86M$387.79M$254.82M
    Operating income$263.87M$257.03M$221.71M$234.84M$210.75M$241.22M$527.59M$306.95M$224.39M$160.89M
    Net income$155.51M$126.71M$13.76M-$77.61M-$113.26M$138.42M$69.02M$279.12M$158.38M$70.20M
    EBITDA$351.90M$306.12M$290.63MN/AN/A$324.28MN/A$360.88M$228.65MN/A
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$220.15M$203.40M$193.29M$295.51M$159.21M$176.31M$156.48M$271.43M$148.53M$146.91M$139.10M$248.45M
    Gross profitN/AN/A$136.11M$131.49M$120.38M$128.05M$123.61M$122.51M$119.50M$121.39M$112.75M$113.52M
    Operating incomeN/AN/A$39.48M$64.58M$59.55M$71.95M$67.39M$67.29M$64.37M$66.97M$57.95M$54.32M
    Net income$28.56M-$25.25M$40.81M$27.15M$22.52M$65.54M$40.30M$46.70M$29.79M$23.98M$26.25M$17.16M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $2.53B exceeded cash and equivalents by $2.46B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$5.49B$5.30B$5.39B$5.75B$5.97B$5.99B$6.07B$6.67B$7.03B$2.27B
    Current assets$189.43M$198.09M$180.53M$201.84M$653.08M$329.01M$262.66M$296.28M$822.24M$184.54M
    Cash and equivalents$71.54M$60.47M$41.28M$49.31M$112.00M$59.08M$39.10M$50.23M$518.63M$25.66M
    Total liabilities$2.67B$2.56B$2.58B$2.69B$2.59B$2.58B$2.58B$3.41B$3.60B$1.25B
    Short-term debt$217.58M$106.55M$94.43M$196.98M$0$1.31B$3.57M$624.00M$641.00M$26.00M
    Long-term debt$2.31B$2.31B$2.32B$2.31B$2.39B$2.37B$2.40B$2.61B$2.75B$1.18B
    Shareholder equity$2.82B$2.74B$2.80B$3.06B$3.38B$3.41B$3.49B$3.25B$3.43B$1.02B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$5.43B$5.51B$5.59B$5.49B$5.56B$5.33B$5.23B$5.30B$5.37B$5.35B$5.37B$5.39B
    Total liabilities$2.59B$2.76B$2.80B$2.67B$2.74B$2.62B$2.53B$2.56B$2.62B$2.59B$2.61B$2.58B
    Cash and equivalents$36.24M$231.58M$116.53M$71.54M$200.60M$95.17M$22.65M$60.47M$63.00M$36.40M$59.93M$41.28M
    Shareholder equity$2.84B$2.75B$2.79B$2.82B$2.82B$2.71B$2.70B$2.74B$2.74B$2.76B$2.77B$2.80B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 88.1% of operating cash flow. Dividends came to 94.3% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$348.61M$310.54M$300.57M$315.73M$356.39M$354.85M$372.48M$360.59M$135.79M$175.93M
    Capital expenditures$41.52M$54.71M$84.86M$54.47M$42.65M$47.35M$25.45M$27.70M$6.95M$1.00M
    Free cash flow$307.09M$255.83M$215.72M$261.26M$313.74M$307.50M$347.02M$332.89M$128.84M$174.93M
    Dividends paid$289.50M$280.15M$277.45M$277.16M$262.92M$278.30M$335.44M$325.22M$182.09M$119.26M
    Share repurchasesN/AN/AN/AN/AN/A$80.09MN/A$499.00KN/AN/A
    Investing cash flow-$377.96M-$109.00M$103.13M-$216.25M-$336.20M-$136.45M$262.84M-$258.49M-$182.56M$142.36M
    Financing cash flow$40.76M-$181.56M-$410.30M-$161.71M$30.14M-$202.11M-$646.18M-$629.34M$598.82M-$300.90M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$128.97M$85.82M$98.36M$87.43M$99.96M$80.96M$80.26M$79.97M$97.65M$80.13M$52.80M$78.74M
    Capital expenditures$15.90M$13.31M$11.85M$17.34M$10.61M$5.79M$7.78M$15.52M$13.83M$12.43M$12.94M$21.06M
    Free cash flow$113.07M$72.51M$86.51M$70.09M$89.35M$75.17M$72.48M$64.44M$83.82M$67.70M$39.86M$57.68M
    Last 12 quarters

    Frequently Asked Questions About SBRA

    What is Sabra Healthcare REIT's annual revenue?

    Sabra Healthcare REIT reported revenue of $787.51M for the fiscal year ended Dec 31, 2025.

    How fast is Sabra Healthcare REIT's revenue growing?

    Revenue was up 11.6% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 15.0%.

    Is Sabra Healthcare REIT profitable?

    Yes. Sabra Healthcare REIT reported net income of $155.51M for the fiscal year ended Dec 31, 2025, with a net margin of 19.7%.

    How much free cash flow does SBRA generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $348.61M minus capital expenditures of $41.52M produced free cash flow of $307.09M.

    How much debt does Sabra Healthcare REIT have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $2.31B, short-term debt of $217.58M and cash and equivalents of $71.54M.